Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902Shunichi Sugawara, T. Nukiwa, Koichi Minato et al.|Annals of Oncology|2015Cited by 111